Search This Blog

Friday, January 8, 2021

DERMAPHARM Receives a Buy rating from Jefferies

 In a research note published by Alexander Thiel, Jefferies advises its customers to buy the stock. The target price is still set at EUR 60.

https://www.marketscreener.com/quote/stock/DERMAPHARM-HOLDING-SE-40718509/news/DERMAPHARM-Receives-a-Buy-rating-from-Jefferies-32148293/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.